NextGen Sciences Appoints New CEO and Expands Service Offering to Include Protein Biomarker Monitoring
13-Nov-2007 -
NextGen Sciences, provider of gene-to-protein products and services, has appointed Dr Mike Pisano as CEO, and has announced the expansion of its portfolio of services to include clinical protein biomarker monitoring.
Dr Pisano joins the Company from Proteomic Research Services (PRS), which was ...
Aventis
biomarker
Life Sciences
+5